Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Terminated 2Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Breast Neoplasms 3Neoplasms 2Brain Neoplasms 2Uterine Cervical Neoplasms 1Lymphoma, Follicular 1Lung Neoplasms 1Kidney Neoplasms 1Inflammatory Breast Neoplasms 1Glioma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Temozolomide 94Radiotherapy 59Bevacizumab 59Radiosurgery 41Carboplatin 27Irinotecan 26Magnetic Resonance Spectroscopy 25Surgical Procedures, Operative 23Etoposide 22Carmustine 20Filgrastim 18Erlotinib Hydrochloride 17Cyclophosphamide 16Cisplatin 16Vincristine 15Lomustine 15Lapatinib 15Sorafenib 13Radiation 13Trastuzumab 12Nivolumab 12Imatinib Mesylate 12Thalidomide 11Surveys and Questionnaires 11Granulocyte Colony-Stimulating Factor 11Radiotherapy, Intensity-Modulated 10Aminolevulinic Acid 10temsirolimus 9Topotecan 9Thiotepa 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Brain Neoplasms × Gadolinium DTPA × Clear all
NCT00395863 2020-11-05

Multihance at 3 Tesla (3T) in Brain Tumors

Bracco Diagnostics, Inc

Phase 4 Completed
46 enrolled 18 charts
CNS

Brain Neoplasms

NCT00681551 2014-12-15

Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Patients With Brain Metastasis

Bayer

Phase 3 Completed
45 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡